跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版

简介

Eduard Puente‑Massaguer

Eduard Puente-Massaguer

Winner of the Host Country Early Career Researcher Award

Icahn School of Medicine at Mount Sinai, USA

Dr. Eduard Puente‑Massaguer’s work focuses on mechanistic, translational vaccinology aimed at developing broadly protective vaccines against infectious diseases. His doctoral training at the Autonomous University of Barcelona centered on designing production platforms for next‑generation HIV‑1 virus‑like particle vaccines and implementing advanced single‑particle analytical methods. He subsequently joined Florian Krammer’s laboratory at the Icahn School of Medicine at Mount Sinai under a Fundación Ramón Areces fellowship, where he advanced the development of universal influenza vaccine strategies using chimeric hemagglutinin and recombinant neuraminidase candidates that are now advancing into Phase I clinical trials. As an Assistant Professor, he leads the development of multivalent vaccines targeting respiratory pathogens and investigates the contribution of non‑hemagglutination‑inhibition immune mechanisms to broad and durable protection.